This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Sanofi. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Emmanuelle Vigne: Innovator in Bispecific Antibodies
Introduction
Emmanuelle Vigne is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding proteins. His work focuses on innovative solutions for treating autoimmune diseases.
Latest Patents
Emmanuelle Vigne holds a patent for CD28/OX40 bispecific antibodies. This patent describes multispecific binding proteins that include a first antigen binding domain (ABD) with specificity to CD28 and a second ABD with specificity to OX40. These proteins are designed to provide new methods for treating autoimmune diseases, showcasing Vigne's commitment to advancing medical science.
Career Highlights
Emmanuelle Vigne is associated with Sanofi, a leading global healthcare company. His role at Sanofi allows him to collaborate with other experts in the field, driving forward innovative research and development.
Collaborations
He has worked alongside notable colleagues such as Gerald Beste and Yanik Bruynooghe. Their combined expertise contributes to the success of their projects and the advancement of therapeutic solutions.
Conclusion
Emmanuelle Vigne's work in bispecific antibodies represents a significant advancement in the treatment of autoimmune diseases. His innovative approach and collaboration with esteemed colleagues highlight his impact on the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile